Tritium labelling of dopaminergic ligands domperidone and (+/-)-7-hydroxy DPAT.
Methods are presented for tritiating the D2 specific dopaminergic antagonist domperidone and D3 specific dopaminergic agonist (+/-)-7-hydroxy DPAT. Techniques to characterize the products of the tritiation are also given.